Effects of glucagon‐like peptide‐1 receptor agonists on histopathological and secondary biomarkers of non‐alcoholic steatohepatitis: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Effects of glucagon‐like peptide‐1 receptor agonists on histopathological and secondary biomarkers of non‐alcoholic steatohepatitis: A systematic review and meta‐analysis

Published:2021-10-27 Issue:2 Volume:24 Page:337-342
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Borodavkin Petr¹,Sheridan William¹,Coelho Claudia²,Oštarijaš Eduard³,Zaïr Zoulikha M.⁴,Miras Alexander D.⁵,McGowan Barbara²,Roux Carel W.⁶,Vincent Royce P.¹⁷,Dimitriadis Georgios K.⁸⁹¹⁰^ORCID

Affiliation:

1. Faculty of Life Sciences and Medicine School of Life Course Sciences, Kingʼs College London London UK

2. Department of Diabetes and Endocrinology Guyʼs and St Thomasʼ NHS Foundation Trust London UK

3. Institute for Translational Medicine University of Pecs Medical School Pecs Hungary

4. Princess Royal University Hospital, Farnborough Common London UK

5. Department of Metabolism, Digestion and Reproduction Imperial College London London UK

6. Diabetes Complication Research Centre School of Medicine and Medical Science, UCD Conway Institute, University College Dublin Belfield Ireland

7. Department of Clinical Biochemistry Kingʼs College Hospital NHS Foundation Trust London UK

8. Department of Endocrinology ASO/EASO COM Kingʼs College Hospital NHS Foundation Trust London UK

9. Obesity, Type 2 Diabetes and Immunometabolism Research Group, Department of Diabetes, Faculty of Life Sciences School of Life Course Sciences, Kingʼs College London London UK

10. Division of Reproductive Health Warwick Medical School, University of Warwick Coventry UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14565

Reference19 articles.

1. Efficacy and safety of glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: A systematic review and meta-analysis

2. Current management of non‐alcoholic steatohepatitis

3. Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future

4. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

5. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes;Frontiers in Immunology;2024-08-01

2. Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study;Hepatology;2024-02-09

3. Obesity management for the hepatologist—What to do, how to do it and why?;Hepatology;2023-09-19

4. The emerging significance of mitochondrial targeted strategies in NAFLD treatment;Life Sciences;2023-09

5. Therapeutic Mechanisms and Clinical Effects of Glucagon-like Peptide 1 Receptor Agonists in Nonalcoholic Fatty Liver Disease;International Journal of Molecular Sciences;2023-05-26